Amgen Inc. buy Royal Bank of Canada
Start price
04.02.26
/
50%
€282.50
Target price
04.02.27
€304.45
Performance (%)
17.19%
Price
27.02.26
€328.55
Summary
This prediction is currently active. The prediction currently has a performance of 17.19%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 04.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Amgen Inc. | 3.334% |
| iShares Core DAX® | -0.383% |
| iShares Nasdaq 100 | -0.411% |
| iShares Nikkei 225® | 1.838% |
| iShares S&P 500 | -0.712% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $335.00 to $360.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat